Schroder Investment Management Group Has $36.85 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA)

Schroder Investment Management Group lifted its holdings in shares of Natera, Inc. (NASDAQ:NTRAFree Report) by 0.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 832,742 shares of the medical research company’s stock after purchasing an additional 792 shares during the period. Schroder Investment Management Group owned 0.69% of Natera worth $36,849,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Treasurer of the State of North Carolina boosted its holdings in Natera by 0.5% in the third quarter. Treasurer of the State of North Carolina now owns 45,469 shares of the medical research company’s stock worth $2,012,000 after acquiring an additional 230 shares in the last quarter. LPL Financial LLC boosted its holdings in Natera by 0.5% in the second quarter. LPL Financial LLC now owns 50,167 shares of the medical research company’s stock worth $2,441,000 after acquiring an additional 233 shares in the last quarter. Xponance Inc. lifted its holdings in shares of Natera by 1.8% in the third quarter. Xponance Inc. now owns 14,506 shares of the medical research company’s stock valued at $642,000 after purchasing an additional 261 shares in the last quarter. King Luther Capital Management Corp lifted its holdings in shares of Natera by 2.1% in the second quarter. King Luther Capital Management Corp now owns 15,811 shares of the medical research company’s stock valued at $769,000 after purchasing an additional 321 shares in the last quarter. Finally, Public Employees Retirement System of Ohio lifted its holdings in shares of Natera by 0.8% in the third quarter. Public Employees Retirement System of Ohio now owns 43,299 shares of the medical research company’s stock valued at $1,897,000 after purchasing an additional 341 shares in the last quarter. Institutional investors own 92.59% of the company’s stock.

Natera Trading Up 1.6 %

Shares of NTRA stock opened at $91.66 on Friday. The company has a quick ratio of 3.96, a current ratio of 4.10 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average price of $69.74 and a two-hundred day moving average price of $57.53. Natera, Inc. has a 12-month low of $36.90 and a 12-month high of $91.99. The firm has a market cap of $11.07 billion, a P/E ratio of -24.18 and a beta of 1.39.

Insiders Place Their Bets

In other news, insider Daniel Rabinowitz sold 35,307 shares of Natera stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $75.09, for a total value of $2,651,202.63. Following the transaction, the insider now owns 204,218 shares in the company, valued at $15,334,729.62. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, insider Daniel Rabinowitz sold 35,307 shares of Natera stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $75.09, for a total value of $2,651,202.63. Following the transaction, the insider now owns 204,218 shares in the company, valued at $15,334,729.62. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director James Healy sold 644,000 shares of the business’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $58.75, for a total value of $37,835,000.00. Following the transaction, the director now owns 42,236 shares in the company, valued at approximately $2,481,365. The disclosure for this sale can be found here. Insiders sold a total of 905,134 shares of company stock valued at $56,638,115 over the last 90 days. Insiders own 9.42% of the company’s stock.

Wall Street Analysts Forecast Growth

NTRA has been the topic of a number of recent research reports. Canaccord Genuity Group raised their target price on Natera from $87.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, February 29th. BTIG Research raised their target price on Natera from $75.00 to $85.00 and gave the company a “buy” rating in a report on Friday, December 29th. Guggenheim started coverage on Natera in a research report on Thursday, December 14th. They set a “buy” rating and a $70.00 price target for the company. Stephens reaffirmed an “overweight” rating and set a $78.00 price target on shares of Natera in a research report on Tuesday, January 30th. Finally, TD Cowen increased their price target on Natera from $82.00 to $87.00 and gave the company an “outperform” rating in a research report on Tuesday, December 12th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $78.36.

View Our Latest Stock Analysis on Natera

About Natera

(Free Report)

Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.

See Also

Want to see what other hedge funds are holding NTRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natera, Inc. (NASDAQ:NTRAFree Report).

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter.